ÂÜÀòÂÒÂ×

Keith Katkin is an experienced leader in the biopharmaceutical sector, currently serving as the CEO of Ambros Therapeutics and the Chairman of the Board of Directors at Eledon Pharmaceuticals. They have held various prominent roles, including President and CEO of Urovant Sciences and Senior Vice President of Sales and Marketing at Avanir Pharmaceuticals. Keith has contributed to the boards of several companies such as Syndax Pharmaceuticals, CoverMyMeds, and Rigel Pharmaceuticals, showcasing their expertise in late-stage development and FDA approvals. They earned their degree from the University of California, Los Angeles - The Anderson School of Management.